Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 859034 | ISIN: US1266501006 | Ticker-Symbol: CVS
Tradegate
12.02.26 | 20:37
65,59 Euro
+1,11 % +0,72
1-Jahres-Chart
CVS HEALTH CORPORATION Chart 1 Jahr
5-Tage-Chart
CVS HEALTH CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
65,4965,7523:00
65,5665,7622:00
PR Newswire
261 Leser
Artikel bewerten:
(1)

CVS Health: Aetna Expands Clinical Collaboration Program to Enhance Support for Hospitals and Provide Personalized Member Care

  • Aetna Clinical Collaboration Program on-track to implement in ten hospitals by end of 2025
  • Early indicators show high member engagement with program projected to reduce 30-day readmissions and length of hospital stay

HARTFORD, Conn., Sept. 22, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced it will scale the Aetna Clinical Collaboration (ACC) program to ten hospitals by year-end, with implementations underway with AdventHealth Shawnee Mission, Houston Methodist and WakeMed Health & Hospitals. The ACC program brings Aetna nurses together with hospital staff, working side-by-side to help Medicare Advantage members get the care and support they need to remain healthy when they return home from the hospital or make the transition into a skilled nursing facility.

Hospital re-admissions happen more often among older populations, with nearly 20 percent of Medicare-insured patients who are hospitalized being readmitted within 30 days of being discharged.* The ACC program aims to improve care outcomes for Aetna Medicare Advantage members, reducing their 30-day readmission rates and emergency room visits while also easing the administrative load on hospitals and clinical personnel.

"Hospital discharge is one the most important-and vulnerable-moments in a patient's journey," said Dr. Ben Kornitzer, Senior Vice President and Aetna Chief Medical Officer. "Patients may be managing new diagnoses, complex medications, and follow-up needs, all while coping with the stress of transitioning back home or to a new facility. By embedding Aetna nurses within hospitals, we're partnering with care teams to ensure that members are supported every step of the way and have the right services to stay well and avoid complications that could lead to readmission."

The first ACC program was implemented earlier this year, with approximately 1 in 4 program members already actively engaged with an Aetna care manager. Once fully implemented at scale, the ACC program is projected to reduce year-over-year 30-day readmissions and hospital length of stay by five percent.

As a leading Medicare Advantage health plan provider, Aetna has more than 4 million members over 65 and plans to continue expanding the ACC program across its network in 2026 and beyond. The company is also implementing ACC for its Commercial business.

*Jencks, S., Williams, M. & Coleman, E. (2009). Rehospitalizations among patients in the Medicare fee-for-service program. New England Journal of Medicine. 360(14),1418-28.

About Aetna

Aetna, a CVS Health business, serves an estimated 36 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care professionals, governmental units, government-sponsored plans, labor groups and expatriates. For more information, visit Aetna.com (e.g., clinical diagnoses, eligibility criteria, participation in a disease state management program).

About CVS Health

CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, a leading pharmacy benefits manager with approximately 87 million plan members, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Media contact

Phil Blando
[email protected]

SOURCE CVS Health

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.